DiaCarta, Inc. vs SAGA Diagnostics
DiaCarta, Inc.
Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection
40 employees · est. 2012 · Pleasanton, United States
SAGA Diagnostics
Redefining the early detection of molecular residual disease (MRD)
97 employees · est. 2016 · Morrisville, United States
DiaCarta, Inc. is the older company (2012 vs 2016); SAGA Diagnostics is the larger of the two.
Side-by-Side Comparison
| Metric | DiaCarta, Inc. | SAGA Diagnostics |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2016 |
| Headquarters | ||
| Headquarters | Pleasanton, United States | Morrisville, United States |
| Employees | ||
| Employees | 40 | 97 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $53.00M | $15.25M |
| Funding Rounds | ||
| Funding Rounds | 2 | 6 |
| Services | ||
| Services | Not tracked yet | Molecular residual disease diagnostics, Pathlight MRD platform, Whole-genome sequencing, Customized digital PCR assays |
| Target Customers | ||
| Target Customers | Not tracked yet | Clinicians, Healthcare providers, Biopharma companies, Cancer patients (especially in early stages) |
| Taxonomy | ||
| Taxonomy | Precision Molecular DiagnosticsTranslational GenomicsCLIA LabLiquid BiopsyCancer Mutation DetectionColorectal Cancer Mutation Detection +9 | Personalized Cancer MedicineDisease MonitoringCirculating Tumor DNALiquid BiopsyMolecular Genetic AnalysesPrecision Oncology +9 |
| Website | ||
| Website | diacarta.com | sagadiagnostics.com |
About DiaCarta, Inc.
DiaCarta, Inc. is a biotechnology startup that has been shaping the future of precision molecular diagnostics since its inception in 2011. The company's slogan, "Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection," reflects its mission to revolutionize cancer diagnosis...
About SAGA Diagnostics
SAGA Diagnostics, founded in 2016, is making significant strides in the biotechnology industry by focusing on personalized cancer medicine. Their unique approach centers on molecular genetic analyses of circulating tumor DNA and tissue biopsies, aiming to revolutionize the early detection of molecul...
Also comparing in this category
Comparing more than these two?
Get DiaCarta, Inc., SAGA Diagnostics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does DiaCarta, Inc. compare?
A PDF of DiaCarta, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare DiaCarta, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at DiaCarta, Inc. on 12 Sep 2024, and SAGA Diagnostics on 23 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
